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Streszczenie
W pracy opisano przypadek noworodka z wrodzoną wadą ser-
ca o typie pojedynczej komory serca, u którego we wczesnym 
okresie po operacji sposobem Norwooda z zespoleniem pra-
wa komora–tętnica płucna zastosowano z powodzeniem żyl-
no-żylne pozaustrojowe wspomaganie układu oddechowego 
(extracorporeal membrane oxygenation – ECMO).
Słowa kluczowe: ECMO żylno-żylne, operacja Norwooda.
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Case reports
Abstract
We describe a case of a newborn with a single-ventricle conge-
nital heart defect, in which veno-venous extracorporeal mem-
brane oxygenation (ECMO) was successfully employed shortly 
after a Norwood operation with right ventricle-to-pulmonary 
artery shunt due to pulmonary insufficiency.
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Introduction
The strategy of employing extracorporeal membrane 
oxygenation (ECMO) in the management of infants with 
a single ventricle and a systemic-to-pulmonary shunt is 
controversial and associated with a high percentage of 
failures [1]. In congenital heart surgery, the use of ECMO 
may result from a number of indications, including preop-
erative support, failure to wean from cardiopulmonary by-
pass (CPB), cardiac arrest, low cardiac output, and severe 
hypoxia [2]. In this study, we report a successful application 
of veno-venous ECMO (VV ECMO) support in a neonate af-
ter a Norwood operation with an RV-to-PA shunt procedure 
performed due to pulmonary insufficiency. 
Case description
The 3.05 kg boy, born at the gestational age of 40 weeks, 
was noted to be tachypneic, cyanotic, and presenting with 
a heart murmur. Echocardiographic examination revealed 
mitral atresia, double outlet right ventricle, subaortic and 
aortic valve stenosis, restrictive patent foramen ovale, mild 
hypoplasia of the distal arch, coarctation of the aorta, and 
patent ductus arteriosus. Mechanical ventilatory support 
and continuous prostaglandin E1 infusion were initiated. 
The patient underwent balloon atrial septostomy and, at 
the age of 19 days, he was subjected to a Norwood pro-
cedure with the placement of a 5 mm right ventricle to 
pulmonary artery (RV-to-PA) shunt. Because of enhanced 
hypoxia and secondary hemodynamic instability, cardiac 
catheterization was performed on day 3 after the opera-
tion. Angiography did not show any obstruction of either 
the RV-to-PA graft or the pulmonary arteries; however, 
an exceptionally long arterial phase with diastolic recoil 
into the central pulmonary arteries was detected, sug-
gesting elevated pulmonary vascular resistance. The fill-
ing of the pulmonary veins was delayed; however, blood 
flow to the left atrium, which appeared to empty normally, 
was visible. Balloon atrial septostomy was performed to 
completely exclude the possibility of left atrial outlet ob-
struction. However, hypoxemia and hypercarbia persisted 
and were unresponsive to several methods of mechanical 
ventilation, as well as nitric oxide administration. Respira-
tory acidosis intensified, with the arterial partial pressure 
of carbon dioxide (PaCO2) above 80 mm Hg and arterial 
partial pressure of oxygen (PaO2) oscillating at about 20 
mm Hg. A decision was made to employ ECMO support. 
As there were no symptoms of low cardiac output or pri-
mary ventricular dysfunction, VV ECMO was employed. 
The right internal jugular vein was accessed percutaneous-
ly, and a 10 F venous cannula was introduced and advanced 
into the right atrium. Veno-venous ECMO was initiated by 
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withdrawing blood from the right atrium and infusing it 
through a femoral venous 5 F catheter. A standard ECMO 
circuit set was employed. Continuous heparin sodium in-
fusion was used in order to maintain the activated clot-
ting time at 180-200 s. The flow rate at the beginning of 
the support, which was 35 ml/kg/min, was gradually re-
duced to 15 ml/kg/min, and then to 7 ml/kg/min shortly 
before the cessation of ECMO. The VV ECMO was contin-
ued for 9 days. After the introduction of ECMO, the child’s 
hemodynamic status stabilized, confirming the hypothesis 
of a pulmonary cause of the instability. A “lung protection 
strategy” was applied by means of reducing the ventilation 
setup from synchronized intermittent mechanical ventila-
tion (SIMV) 35/min, PIP 41 mm Hg, positive end-expiratory 
pressure (PEEP) 6 mm Hg, tidal volume (TV) 75 ml, fraction 
of inspired oxygen (FiO2) 1.0 to SIMV 20/min, peak inspira-
tory pressure (PIP) 33 mm Hg, PEEP 1 mm Hg, TV 60 ml, 
FiO2 0.5. Fluctuations of blood gas values are presented in 
Fig. 1. The pO2 value was low, but pCO2 was controllable 
and was maintained within the normal range. Urine output 
was satisfactory, and no neurological sequelae attributable 
to ECMO were observed. During the extracorporeal sup-
port, the patient was receiving antibiotic treatment due to 
Escherichia coli bacteremia and radiological symptoms of 
pneumonia. After weaning from ECMO, the patient dem-
onstrated continued respiratory disability, received positive 
pressure ventilation/mechanical ventilatory support for 
25 days, and was discharged 42 days after the operation 
with systemic oxygen saturation of 71-80% in room air.
Discussion
The ECMO in neonates with single-ventricle defects is 
applied due to low cardiac output, cardiac arrest, or ven-
tricular dysfunction after surgical procedures [3, 4]. We 
have described a rare situation in which ECMO support was 
applied due to pulmonary insufficiency of unclear cause, 
most likely a combination of high pulmonary vascular re-
sistance and pneumonia. Usually, ECMO support in neo-
nates after Norwood procedures is performed by means of 
AV ECMO; therefore, reports concerning VV CO2 removal in 
neonates with single-ventricle physiology are rare. The use 
of extracorporeal life support (ECLS) in patients after Nor-
wood procedures, who constitute a particularly challenging 
subgroup with reportedly poorer overall outcomes, con-
tinues to raise controversy [5]. The lower survival rate in 
these patients has been partially attributed to an imbal-
ance between systemic and pulmonary perfusion and its 
associated impact on coronary perfusion due to the dias-
tolic run-off into the pulmonary bed [6]. The replacement 
of the classic systemic-to-pulmonary shunt with an RV-to-
PA shunt eliminates the dilemma related to the selection 
of shunt management strategy during ECMO. Additionally, 
the better hemodynamic conditions offered by this type of 
shunt may allow for less hemodynamically invasive ECLS in 
the form of VV ECMO for pulmonary insufficiency. 
Veno-venous ECMO is an alternative to veno-arterial 
bypass that provides pulmonary gas exchange, but no 
direct cardiac support. Hypoxia and acidosis, as well as 
the increased mean intrathoracic pressure, resulting from 
the ventilatory strategies used to maintain oxygenation, 
decrease cardiac output and tissue oxygen delivery. The im-
proved venous blood oxygenation and lower airway pres-
sure achieved with VV ECMO have substantially improved 
cardiac function in our patient, as well as allowing for a re-
duction of the possible “volume and pressure trauma” for 
his lungs [7]. 
Some additional potential advantages of VV bypass 
are: sparing the carotid artery from ligation and keeping 
the chest closed (only a venous access is necessary), main-
taining a normal pulsatile blood flow pattern, and main-
taining pulmonary flow with oxygenated blood, which may 
decrease pulmonary vascular resistance. Veno-venous 
ECMO provides a more stable hemodynamic situation in 
comparison to AV support and does not radically change 
the Qp/Qs ratio. 
Veno-venous ECMO is possible with percutaneous ac-
cess only, with easy bleeding control and reduced circuit 
installation time. In our case, the size of the cannulas was 
appropriate to maintain PaCO2 in the normal range. Recent 
neonatal studies have shown that AV and VV ECLS support 
are clinically equivalent in terms of outcome in similar neo-
natal patients with severe respiratory failure [8]. In older 
children, double-lumen cannulas may facilitate rapid per-
cutaneous establishment of VV ECMO. 
The separation of pulmonary and cardiac support in this 
“physiologically challenged” population of patients makes 
the VV ECMO technique easy to control, and provides me-
chanical ventilatory management similar to the standard 
technique, while preventing damage to the diseased lung by 
reducing the setup parameters. Cannulation of the right atri-
um and femoral vein may decrease the “recirculation effect”. 
Veno-venous ECMO after Norwood operation with RV-
PA shunt may be especially recommended for treating pul-
monary disturbances, including pulmonary hypertension 
and pneumonia (e.g. viral). 
In conclusion, the survival of patients with a single ven-
tricle after Norwood procedures with RV-to-PA shunts may 
be improved by VV ECMO support.
Fig. 1. Partial pressure of Pa2 and PaCO2 during ECMO support in 
neonate after Norwood with RV-PA conduit
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